Venture Capital, Venture Cancer or Both?

[audio mp3="https://pdcn.co/e/rss.art19.com/episodes/615d831c-fcae-40b9-b6f5-561971ae5a8c.mp3?rss_browser=BAhJIgljdXJsBjoGRVQ%3D--435795d5c850773aaa4739d968bd77a1dfd6f301"][/audio] Venture Capital, Venture Cancer or Both?

Stand-up comedian Ben Freeberg is a young adult survivor of testicular cancer. In 2022, he turned his pain into purpose, leveraging his career in finance, and launched create Oncology Ventures, an early-stage, cancer-focused venture fund investing in start-ups whose purpose is to fundamentally change the way cancer care is designed and delivered at scale. As Managing Partner, Ben oversees pretty much everything while working his way into the world of cancer advocacy, start-up culture, and the sometimes dark underbelly of the role non-profits play (or don't play) in the space. I know this is a first-of-its-kind venture, so time will tell if everyone else is as intelligent as Ben hopes they are.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kenny Kane

Kenny Kane is an entrepreneur, writer, and nonprofit innovator with 15+ years of experience leading organizations at the intersection of business, technology, and social impact. He is the CEO of Firmspace, CEO of the Testicular Cancer Foundation, and CTO/co-founder of Gryt Health.

A co-founder of Stupid Cancer, Kenny has built national awareness campaigns and scaled teams across nonprofits, health tech, and real estate. As an author, he writes about leadership, resilience, and building mission-driven organizations.

Previous
Previous

The Local Pharmacists' Advocate

Next
Next

Make Waiting Room Times Suck Less